Legalization
After a spike in demand for research, the DEA is proposing increased quotas for controlled substances including MDMA, LSD, psilocybin and cannabis
Hi, what are you looking for?
Mugglehead Investment Magazine
Research
Cannabis
A majority of physicians aren't equipped to talk about medical cannabis, and patients often look for information elsewhere
Business
Taking sublingual oils proved beneficial for chronic pain, nausea, anxiety and a list of other common ailments
Canada
On average, unregulated bud tested had 10%-lower THC than advertised
News
A study linked self reports of being stoned with time and movement in young adults
Business
The firm says expenses will increase as research and 'important progress' continues
Business
According to data firm BDSA, rapid expansion of US markets is the primary driver of cannabis sales growth over the next 5 years
Health and Safety
The Cross-Party Group on Medical Cannabis hopes to shed light on developing treatments
Canada
The research relied on an inaccurate timeframe and didn't distinguish between legal and illegal products, critics say
Business
Recreational sales make up the bulk of transactions, but patients stick to the medical system for a number of reasons
